The Health Ministry released the India TB report 2021 on March 24. The report was released on the occasion of World TB Day 2021.
Key Points
- As per the India TB 2021 report, in 2020, there were 18.05 TB notifications, which was a decrease of 24% from 2019 due to the disruptions caused by the pandemic.
- Between January and February 2020, the notifications were on an upward trajectory, with 6% more cases reported in the same period in 2019.
- According to the report, due to the lockdown, notifications in the public sector decreased by 38% and 44% in the private sector in April and May.
- 04 lakh TB cases were reported in 2019. For these cases, the success rate of treatment was 82%, the mortality rate was 4%, 4% of patients were lost to follow up and treatment failure and regimen change after initiation of treatment was around 3%.
- As per the report, the approved budgets toward the programme have increased substantially, from Rs 640 crore in 2016-17 to Rs 3,333 crores in 2019-20. However, there was a decrease in the budget to Rs 3,110 crore in 2020-21.
- More than 95% of all cases reported were initiated on treatment in the year 2020.
- The treatment success rate for patients reported in 2019 was 82% (79% in the private sector and 83% among patients in the public sector).
A total of 20,892 (42%) of patients were initiated on a shorter MDR-TB regimen at the time of diagnosis. This is a decline in comparison to the year 2019. 71% of the patients were initiated on the shorter MDR-TB regimen in 2019. Also, newer drug regimens were introduced for MDR-TB patients in 2019. In 2020, over 20,000 patients were initiated on Bedaquiline and 652 patients [including paediatric TB patients in the age group of 6-17] were initiated on Delamanid.
